Two New Sites Available for Early Access to Alpharadin
There are now two new, additional sites added to the Early Access Trial of the investigational treatment known as Radium-233 or Alpharadin for men with castrate resistant prostate cancer with multiple bone metastases. This post [...]
Help AdvancedProstateCancer.net stay alive
We won't let you fight your prostate cancer alone. Our mission is simple. We are men, fighting cancer, together. We share lifesaving information about the newest treatments, best (and worst) doctors and clinical trial admissions. [...]
The Need to Develop Personalized Medicine Before We Cause Great Harms
Researchers at the Harvard Medical School investigated the effect of androgen deprivation in a preclinical mouse model of stable high grade prostatic intraepithelial neoplasia induced by the loss of the PTEN tumor suppressor. They found [...]
Tissue Study Could Reshape Advanced Prostate Cancer Treatment & Bio-Markers
A comprehensive study of prostate cancer tissue done in the UK has revealed that a completely new gene network takes over driving the cancer in men who are castrate resistant. The research was published in [...]
Mortality is Directly Related to Both Time to Recurrence and Risk Level of Prostate Cancer
Mortality prospects after a prostate cancer recurrences following a radical prostatectomy has always been assumed to be directly related to the early development of metastases. A study from Melbourne Australia indicates that men with low-risk [...]
Acknowledging That We Need to Merge Science with Personal Preferences When It Comes to Treating Advanced Prostate Cancer
There has been much discussion about the timing of treatments now that we have new drugs available to treat advanced prostate cancer. However, today’s technology does not allow us to know what the best sequencing [...]